DEVELOPMENT
Using wide experience, Labofarm wants to offer its patients wider and wider opportunities of safe self-healing. Because of this we constantly run research and development work, which shows new therapeutic directions.
New registrations of formulations that Labofarm is working on at present will allow making the variety of products more extensive. It will also allow introduction of new medicine forms, formulations based on isolated fraction and preparation that will bring new therapeutic possibilities due to the combination of herbal contents, vitamins and minerals.

The company's dynamic development does not only aim at new registrations but also hopes to receive bigger approval from its patients and institutions in Poland as well as abroad. GMP (Good Manufacturing Practice) audit conducted by Quality Assessment Systems Office attached to the Drug Institute, approved conformity of production conditions, technological and organization solutions of Labofarm with the highest global standards and expectations. The GMP certificate gives the company an opportunity of further expansion into foreign markets and efficient competition with world-wide range producers.


EXPERIMENTAL PLANTATIONS
Research on modern natural-based medicines would be less efficient if they were conducted without strict analyses of natural resources. That's why Labofarm owns a private experimental plant, which allows experimenting with contents of active substances in plant resources depending on species, period of vegetation, cultivation and the harvest of resources. It chooses the best species and creates the finest growth conditions possible. With the acquired knowledge and experience it benefits resource suppliers who cooperate permanently with our company.